arrow
C

Carlos Noe Farfán-Morales

Center for Research and Advanced Studies
H指数:15
被引数:742

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A network-driven antiviral discovery pipeline for emerging RNA viruses: a critical perspective from the Red Mexicana de Desarrollo de Antivirales (RMDA)

网络驱动的抗病毒发现流程用于新兴RNA病毒:来自墨西哥抗病毒发展网络(RMDA)的批判性视角

2026-08-140
OAAI
Small extracellular vesicles from DENV2-infected C6/36 cells show viral infection in vitro and in vivo
2026-01-270
OA
Fisetin as an Antiviral Agent Targeting the RNA-Dependent RNA Polymerase of SARS-CoV-2: Computational Prediction and In Vitro Experimental Validation

Fisetin作为一种靶向SARS-CoV-2 RNA依赖性RNA聚合酶的抗病毒剂:计算预测与体外实验验证

2025-12-100
OAAI
The protective role of metformin against severe dengue disease in patients with type 2 diabetes mellitus: a preliminary report in Mexico
2025-11-010
PRE
The pregnane X receptor is a novel host target for dengue virus infection that reprograms lipid metabolism and suppresses the immune response

孕烷X受体是登革病毒感染的新型宿主靶点,其能重编程脂质代谢并抑制免疫应答。

2025-09-180
PRE
Antiviral effect of metformin and phenformin analogs against dengue in Huh-7 cells and AG129 mice

二甲双胍和苯乙双胍类似物对登革病毒的抗病毒作用(在Huh-7细胞和AG129小鼠中)

2025-08-230
PREAI
Pharmacological inhibition of the RhoA pathway by melatonin reduces viral replication and proinflammatory response against ZIKV and DENV-4 neuroinfections

褪黑素通过药理抑制RhoA通路,可降低寨卡病毒和登革热病毒4型神经感染中的病毒复制和促炎反应。

2025-08-020
OA
Antiviral Effect of Microalgae Phaeodactylum tricornutum Protein Hydrolysates against Dengue Virus Serotype 2
2024-08-141
OAAI
Association between lipid profile and clinical outcomes in COVID-19 patients

新型冠状病毒肺炎患者血脂与临床结局的关系

2024-05-277
OAAI
A Dual Pharmacological Strategy against COVID-19: The Therapeutic Potential of Metformin and Atorvastatin

针对新型冠状病毒肺炎的双重药理学策略: 二甲双胍和阿托伐他汀的治疗潜力

2024-02-135
OAAI